Randomized, controlled trial of insulin for acute poststroke hyperglycemia
- 26 April 2010
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 67 (5), 570-578
- https://doi.org/10.1002/ana.21983
Abstract
Objective Poststroke hyperglycemia is common and is associated with increased risk of death and dependence, but appropriate management remains uncertain. Glucose potassium insulin (GKI) infusion did not benefit patients with moderate poststroke hyperglycemia in a recent trial. Using magnetic resonance imaging (MRI), previous studies identified a relationship between recruitment of ischemic tissue to the final infarct and hyperglycemia, possibly mediated by brain lactic acidosis. Methods We undertook a randomized, placebo‐controlled trial of GKI infusion in patients with blood glucose >126mg/dl (7mmol/l) within 24 hours of ischemic stroke. The primary endpoint was infarct growth on MRI between baseline and day 7. Brain lactate concentrations were measured with magnetic resonance spectroscopy. Results Forty patients were randomized, 15 to saline and 25 to GKI infusions of different durations. Capillary blood glucose concentrations were lowered significantly from 6 to 12 hours after GKI initiation. There was no significant difference on any measure of infarct growth between the GKI and saline groups. In a secondary analysis, GKI was associated with significantly greater infarct growth in patients with complete intracranial vessel occlusion compared with controls (p = 0.011 for group–vessel status interaction). Brain lactate levels increased in control subjects, but were significantly lower with GKI infusion. Predominantly asymptomatic hypoglycemia occurred in 76% of GKI‐treated subjects. Interpretation GKI infusion within 24 hours of stroke lowered blood glucose and attenuated an increase in brain lactate, but did not affect cerebral infarct growth. Exploratory analysis found that GKI infusion was associated with greater infarct growth in patients with persistent arterial occlusion, and with a high incidence of asymptomatic hypoglycemia. ANN NEUROL 2010;67:570–578Keywords
This publication has 31 references indexed in Scilit:
- Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study dataCMAJ : Canadian Medical Association Journal, 2009
- Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II TrialStroke, 2008
- Treatment of Hyperglycemia In Ischemic Stroke (THIS)Stroke, 2008
- Revascularization End Points in Stroke Interventional TrialsStroke, 2005
- Reliability of the Modified Rankin Scale Across Multiple RatersStroke, 2005
- Improving the Assessment of Outcomes in StrokeStroke, 2002
- Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic PatientsStroke, 2001
- Treatment in a Combined Acute and Rehabilitation Stroke UnitStroke, 1999
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989